Effect of a differentiated service delivery model on virological failure in adolescents with HIV in Zimbabwe (Zvandiri): a cluster-randomised controlled trial

Summary: Background: Adolescents living with HIV face challenges to their wellbeing and antiretroviral therapy adherence and have poor treatment outcomes. We aimed to evaluate a peer-led differentiated service delivery intervention on HIV clinical and psychosocial outcomes among adolescents with HI...

Full description

Bibliographic Details
Main Authors: Webster Mavhu, PhD, Nicola Willis, MPhil, Juliet Mufuka, MBA, Sarah Bernays, PhD, Maureen Tshuma, MSc, Collin Mangenah, MSc, Hendramoorthy Maheswaran, PhD, Walter Mangezi, MMed, Tsitsi Apollo, MD, Ricardo Araya, ProfPhD, Helen A Weiss, ProfPhD, Frances M Cowan, ProfMD
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X19305261
_version_ 1819079291588050944
author Webster Mavhu, PhD
Nicola Willis, MPhil
Juliet Mufuka, MBA
Sarah Bernays, PhD
Maureen Tshuma, MSc
Collin Mangenah, MSc
Hendramoorthy Maheswaran, PhD
Walter Mangezi, MMed
Tsitsi Apollo, MD
Ricardo Araya, ProfPhD
Helen A Weiss, ProfPhD
Frances M Cowan, ProfMD
author_facet Webster Mavhu, PhD
Nicola Willis, MPhil
Juliet Mufuka, MBA
Sarah Bernays, PhD
Maureen Tshuma, MSc
Collin Mangenah, MSc
Hendramoorthy Maheswaran, PhD
Walter Mangezi, MMed
Tsitsi Apollo, MD
Ricardo Araya, ProfPhD
Helen A Weiss, ProfPhD
Frances M Cowan, ProfMD
author_sort Webster Mavhu, PhD
collection DOAJ
description Summary: Background: Adolescents living with HIV face challenges to their wellbeing and antiretroviral therapy adherence and have poor treatment outcomes. We aimed to evaluate a peer-led differentiated service delivery intervention on HIV clinical and psychosocial outcomes among adolescents with HIV in Zimbabwe. Methods: 16 public primary care facilities (clusters) in two rural districts in Zimbabwe (Bindura and Shamva) were randomly assigned (1:1) to provide enhanced HIV care support (the Zvandiri intervention group) or standard HIV care (the control group) to adolescents (aged 13–19 years) with HIV. Eligible clinics had at least 20 adolescents in pre-ART or ART registers and were geographically separated by at least 10 km to minimise contamination. Adolescents were eligible for inclusion if they were living with HIV, registered for HIV care at one of the trial clinics, and either starting or already on ART. Exclusion criteria were being too physically unwell to attend clinic (bedridden), psychotic, or unable to give informed assent or consent. Adolescents with HIV at all clinics received adherence support through adult counsellors. At intervention clinics, adolescents with HIV were assigned a community adolescent treatment supporter, attended a monthly support group, and received text messages, calls, home visits, and clinic-based counselling. Implementation intensity was differentiated according to each adolescent's HIV vulnerability, which was reassessed every 3 months. Caregivers were invited to a support group. The primary outcome was the proportion of adolescents who had died or had a viral load of at least 1000 copies per μL after 96 weeks. In-depth qualitative data were collected and analysed thematically. The trial is registered with Pan African Clinical Trial Registry, number PACTR201609001767322. Findings: Between Aug 15, 2016, and March 31, 2017, 500 adolescents with HIV were enrolled, of whom four were excluded after group assignment owing to testing HIV negative. Of the remaining 496 adolescents, 212 were recruited at Zvandiri intervention sites and 284 at control sites. At enrolment, the median age was 15 years (IQR 14–17), 52% of adolescents were female, 81% were orphans, and 47% had a viral load of at least 1000 copies per μL. 479 (97%) had primary outcome data at endline, including 28 who died. At 96 weeks, 52 (25%) of 209 adolescents in the Zvandiri intervention group and 97 (36%) of 270 adolescents in the control group had an HIV viral load of at least 1000 copies per μL or had died (adjusted prevalence ratio 0·58, 95% CI 0·36–0·94; p=0·03). Qualitative data suggested that the multiple intervention components acted synergistically to improve the relational context in which adolescents with HIV live, supporting their improved adherence. No adverse events were judged to be related to study procedures. Severe adverse events were 28 deaths (17 in the Zvandiri intervention group, 11 in the control group) and 57 admissions to hospital (20 in the Zvandiri intervention group, 37 in the control group). Interpretation: Peer-supported community-based differentiated service delivery can substantially improve HIV virological suppression in adolescents with HIV and should be scaled up to reduce their high rates of morbidity and mortality. Funding: Positive Action for Adolescents Program, ViiV Healthcare.
first_indexed 2024-12-21T19:26:39Z
format Article
id doaj.art-adf3b2f3158e4c30827516bf90b7458a
institution Directory Open Access Journal
issn 2214-109X
language English
last_indexed 2024-12-21T19:26:39Z
publishDate 2020-02-01
publisher Elsevier
record_format Article
series The Lancet Global Health
spelling doaj.art-adf3b2f3158e4c30827516bf90b7458a2022-12-21T18:52:49ZengElsevierThe Lancet Global Health2214-109X2020-02-0182e264e275Effect of a differentiated service delivery model on virological failure in adolescents with HIV in Zimbabwe (Zvandiri): a cluster-randomised controlled trialWebster Mavhu, PhD0Nicola Willis, MPhil1Juliet Mufuka, MBA2Sarah Bernays, PhD3Maureen Tshuma, MSc4Collin Mangenah, MSc5Hendramoorthy Maheswaran, PhD6Walter Mangezi, MMed7Tsitsi Apollo, MD8Ricardo Araya, ProfPhD9Helen A Weiss, ProfPhD10Frances M Cowan, ProfMD11Centre for Sexual Health and HIV/AIDS Research (CeSHHAR), Harare, Zimbabwe; Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK; Correspondence to: Dr Webster Mavhu, Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UKAfricaid, Harare, ZimbabweCentre for Sexual Health and HIV/AIDS Research (CeSHHAR), Harare, ZimbabweSchool of Public Health, University of Sydney, Sydney, Australia; MRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UKCentre for Sexual Health and HIV/AIDS Research (CeSHHAR), Harare, ZimbabweCentre for Sexual Health and HIV/AIDS Research (CeSHHAR), Harare, ZimbabweInstitute of Psychology, Health, and Society, University of Liverpool, Liverpool, UKDepartment of Psychiatry, University of Zimbabwe College of Health Sciences, Harare, ZimbabweAIDS and TB Unit, Ministry of Health and Child Care, Harare, ZimbabweHealth Services and Population Research Department, King's College London, London, UKMRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UKCentre for Sexual Health and HIV/AIDS Research (CeSHHAR), Harare, Zimbabwe; Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UKSummary: Background: Adolescents living with HIV face challenges to their wellbeing and antiretroviral therapy adherence and have poor treatment outcomes. We aimed to evaluate a peer-led differentiated service delivery intervention on HIV clinical and psychosocial outcomes among adolescents with HIV in Zimbabwe. Methods: 16 public primary care facilities (clusters) in two rural districts in Zimbabwe (Bindura and Shamva) were randomly assigned (1:1) to provide enhanced HIV care support (the Zvandiri intervention group) or standard HIV care (the control group) to adolescents (aged 13–19 years) with HIV. Eligible clinics had at least 20 adolescents in pre-ART or ART registers and were geographically separated by at least 10 km to minimise contamination. Adolescents were eligible for inclusion if they were living with HIV, registered for HIV care at one of the trial clinics, and either starting or already on ART. Exclusion criteria were being too physically unwell to attend clinic (bedridden), psychotic, or unable to give informed assent or consent. Adolescents with HIV at all clinics received adherence support through adult counsellors. At intervention clinics, adolescents with HIV were assigned a community adolescent treatment supporter, attended a monthly support group, and received text messages, calls, home visits, and clinic-based counselling. Implementation intensity was differentiated according to each adolescent's HIV vulnerability, which was reassessed every 3 months. Caregivers were invited to a support group. The primary outcome was the proportion of adolescents who had died or had a viral load of at least 1000 copies per μL after 96 weeks. In-depth qualitative data were collected and analysed thematically. The trial is registered with Pan African Clinical Trial Registry, number PACTR201609001767322. Findings: Between Aug 15, 2016, and March 31, 2017, 500 adolescents with HIV were enrolled, of whom four were excluded after group assignment owing to testing HIV negative. Of the remaining 496 adolescents, 212 were recruited at Zvandiri intervention sites and 284 at control sites. At enrolment, the median age was 15 years (IQR 14–17), 52% of adolescents were female, 81% were orphans, and 47% had a viral load of at least 1000 copies per μL. 479 (97%) had primary outcome data at endline, including 28 who died. At 96 weeks, 52 (25%) of 209 adolescents in the Zvandiri intervention group and 97 (36%) of 270 adolescents in the control group had an HIV viral load of at least 1000 copies per μL or had died (adjusted prevalence ratio 0·58, 95% CI 0·36–0·94; p=0·03). Qualitative data suggested that the multiple intervention components acted synergistically to improve the relational context in which adolescents with HIV live, supporting their improved adherence. No adverse events were judged to be related to study procedures. Severe adverse events were 28 deaths (17 in the Zvandiri intervention group, 11 in the control group) and 57 admissions to hospital (20 in the Zvandiri intervention group, 37 in the control group). Interpretation: Peer-supported community-based differentiated service delivery can substantially improve HIV virological suppression in adolescents with HIV and should be scaled up to reduce their high rates of morbidity and mortality. Funding: Positive Action for Adolescents Program, ViiV Healthcare.http://www.sciencedirect.com/science/article/pii/S2214109X19305261
spellingShingle Webster Mavhu, PhD
Nicola Willis, MPhil
Juliet Mufuka, MBA
Sarah Bernays, PhD
Maureen Tshuma, MSc
Collin Mangenah, MSc
Hendramoorthy Maheswaran, PhD
Walter Mangezi, MMed
Tsitsi Apollo, MD
Ricardo Araya, ProfPhD
Helen A Weiss, ProfPhD
Frances M Cowan, ProfMD
Effect of a differentiated service delivery model on virological failure in adolescents with HIV in Zimbabwe (Zvandiri): a cluster-randomised controlled trial
The Lancet Global Health
title Effect of a differentiated service delivery model on virological failure in adolescents with HIV in Zimbabwe (Zvandiri): a cluster-randomised controlled trial
title_full Effect of a differentiated service delivery model on virological failure in adolescents with HIV in Zimbabwe (Zvandiri): a cluster-randomised controlled trial
title_fullStr Effect of a differentiated service delivery model on virological failure in adolescents with HIV in Zimbabwe (Zvandiri): a cluster-randomised controlled trial
title_full_unstemmed Effect of a differentiated service delivery model on virological failure in adolescents with HIV in Zimbabwe (Zvandiri): a cluster-randomised controlled trial
title_short Effect of a differentiated service delivery model on virological failure in adolescents with HIV in Zimbabwe (Zvandiri): a cluster-randomised controlled trial
title_sort effect of a differentiated service delivery model on virological failure in adolescents with hiv in zimbabwe zvandiri a cluster randomised controlled trial
url http://www.sciencedirect.com/science/article/pii/S2214109X19305261
work_keys_str_mv AT webstermavhuphd effectofadifferentiatedservicedeliverymodelonvirologicalfailureinadolescentswithhivinzimbabwezvandiriaclusterrandomisedcontrolledtrial
AT nicolawillismphil effectofadifferentiatedservicedeliverymodelonvirologicalfailureinadolescentswithhivinzimbabwezvandiriaclusterrandomisedcontrolledtrial
AT julietmufukamba effectofadifferentiatedservicedeliverymodelonvirologicalfailureinadolescentswithhivinzimbabwezvandiriaclusterrandomisedcontrolledtrial
AT sarahbernaysphd effectofadifferentiatedservicedeliverymodelonvirologicalfailureinadolescentswithhivinzimbabwezvandiriaclusterrandomisedcontrolledtrial
AT maureentshumamsc effectofadifferentiatedservicedeliverymodelonvirologicalfailureinadolescentswithhivinzimbabwezvandiriaclusterrandomisedcontrolledtrial
AT collinmangenahmsc effectofadifferentiatedservicedeliverymodelonvirologicalfailureinadolescentswithhivinzimbabwezvandiriaclusterrandomisedcontrolledtrial
AT hendramoorthymaheswaranphd effectofadifferentiatedservicedeliverymodelonvirologicalfailureinadolescentswithhivinzimbabwezvandiriaclusterrandomisedcontrolledtrial
AT waltermangezimmed effectofadifferentiatedservicedeliverymodelonvirologicalfailureinadolescentswithhivinzimbabwezvandiriaclusterrandomisedcontrolledtrial
AT tsitsiapollomd effectofadifferentiatedservicedeliverymodelonvirologicalfailureinadolescentswithhivinzimbabwezvandiriaclusterrandomisedcontrolledtrial
AT ricardoarayaprofphd effectofadifferentiatedservicedeliverymodelonvirologicalfailureinadolescentswithhivinzimbabwezvandiriaclusterrandomisedcontrolledtrial
AT helenaweissprofphd effectofadifferentiatedservicedeliverymodelonvirologicalfailureinadolescentswithhivinzimbabwezvandiriaclusterrandomisedcontrolledtrial
AT francesmcowanprofmd effectofadifferentiatedservicedeliverymodelonvirologicalfailureinadolescentswithhivinzimbabwezvandiriaclusterrandomisedcontrolledtrial